<p>In this episode, David interviews Dr. Hans Eriksson: clinical psychiatrist and Chief Medical Officer at HMNC Brain Health, which is currently in Phase 2 trials for Ketabon, a non-dissociative, prolonged-release oral capsule. </p> <p>www.psychedelicstoday.com</p>

PT358 – Dr. Rick Barnett, Psy.D – Contexts of Use: Exploring the Various Paradigms of Psychedelics

Psychedelics Today is the planetary leader in psychedelic education, media, and advocacy. Covering up-to-the-minute developments and diving deep into crucial topics bridging the scientific, academic, philosophical, societal, and cultural, Psychedelics Today is leading the discussion in this rapidly evolving ecosystem.